Moderna's chief medical officer on its blockb...

Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Axios cofounder and CEO Jim VandeHei joins Axios Re:Cap senior producer Naomi Shavin to talk about what journalists got right a ...  Show more

Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major ...  Show more

Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it m ...  Show more

It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.

But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine ...

Recent data from the C.D.C. has found that not only can vaccinated people get infected with the Delta variant of the coronavirus, though instances are rare, but they also can potentially spread the virus just as much as an unvaccinated person.

What are the practical impl ...

Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ...